Progyny (PGNY) Stock Price
Progyny Price
Over the last 8 years Progyny grew revenue by 51.2% annually, reaching 1.29 B USD. Earnings per share have grown at 83.4% per year over the last 7 years. For Progyny, the net margin of 4.5% is down versus 13.1% a few years ago. The consensus 12-month price target for Progyny is 35.00 USD, about 26.5% above where the stock trades today. Of 18 analysts, 15 rate the stock a buy — an overall Buy consensus.
Progyny stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Progyny business model & stock analysis
Frequently asked questions about Progyny
Progyny Inc. is a leading fertility benefits management company. Their business model revolves around providing comprehensive fertility benefits to individuals and employers. Progyny's services include personalized care coordination, expert medical guidance, and access to a wide network of fertility specialists. By partnering with Progyny, individuals and employers are able to navigate the complex fertility landscape with ease, gaining access to innovative treatments and technologies. With a strong focus on patient outcomes and cost containment, Progyny aims to enhance the fertility journey for all involved parties. Through their unique business model, Progyny strives to empower individuals, improve outcomes, and build a more inclusive future for fertility care.
Progyny Inc is primarily active in the healthcare industry.
Progyny Inc faces competition from other companies in the fertility benefits industry such as Carrot, WINFertility, and Future Family. These companies provide similar services and solutions for infertility treatments and family-building support. However, Progyny Inc distinguishes itself by offering a comprehensive and personalized approach to fertility benefits, leveraging data analytics and providing access to a nationwide network of fertility specialists. With its innovative solutions and strategic partnerships, Progyny Inc stands out as a leading player in the market, committed to empowering individuals and couples on their journey to parenthood.
Progyny Inc. is a prominent fertility benefits management company headquartered in New York. Established in 2015, Progyny offers comprehensive fertility solutions to employers and their employees, aiming to simplify and enhance the fertility journey. With a mission to make advancements in reproductive medicine accessible to a wider population, Progyny combines innovative technology, personalized care, and financial options to cater to diverse fertility needs. This company has successfully partnered with a vast network of world-class fertility specialists and providers to deliver exceptional outcomes. Progyny Inc. continues to play a crucial role in revolutionizing fertility benefits and ensuring that individuals can pursue their dreams of starting a family smoothly.
Progyny Inc has achieved several significant milestones since its inception. The company has successfully established itself as a leader in fertility benefits management, offering comprehensive solutions to employers and individuals. Progyny Inc has rapidly expanded its network of fertility clinics and providers, ensuring a wide range of options for patients. With a focus on personalized care and cutting-edge technology, Progyny Inc has helped thousands of individuals and couples navigate their fertility journeys. The company's commitment to research and innovations in reproductive medicine has further solidified its position in the industry. Progyny Inc continues to make strides towards revolutionizing fertility care and supporting individuals in building their families.
Progyny Inc is primarily present in the United States.
Progyny Inc represents a strong commitment to reproductive health and family building. The company's corporate philosophy revolves around providing comprehensive fertility benefits and exceptional patient care. Progyny Inc strongly believes in empowering individuals and couples to make informed decisions about their fertility journeys. Their values include compassion, integrity, innovation, and a dedication to improving the lives of individuals struggling with infertility. Progyny Inc's mission is to ensure cost-effective, high-quality fertility solutions and support, helping individuals and families achieve their dream of having a baby.
Analysts currently set an average price target of 34.86 USD for the Progyny stock (median: 35.00 USD), implying +26.0 % versus the latest price. The consensus is based on 18 analyst ratings.
18 analysts currently rate the Progyny stock: 15 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Progyny to generate revenue of 1.37 B USD and earnings per share of 1.24 USD.
Converted at the current exchange rate, the Progyny share trades at 24.67 EUR (27.67 USD).
The Progyny share (PGNY) is listed on 1 stock exchanges, including: NASDAQ (PGNY).
Progyny Inc is a leading healthcare company specializing in fertility treatments and services. The company was founded in 2008 and is headquartered in New York City. Progyny offers a comprehensive range of services to its customers, ranging from diagnosis to family support. Progyny provides its customers with personalized fertility programs that consider both medical and psychological aspects. The program begins with a comprehensive diagnosis and counseling to determine where the customer is on the fertility spectrum and what treatment options are available to them. Then, a treatment plan tailored to the specific needs of the customer is created. Progyny works with a range of doctors and clinics to ensure that its customers receive the best available treatment. An important part of Progyny's business model is its fertility network. The company has partnership agreements with over 500 fertility clinics and centers nationwide, producing over 2,000 success stories per year. Thanks to its network, Progyny has the ability to offer its customers comprehensive access to diagnostic and therapeutic services to achieve a successful pregnancy. Progyny also offers an online platform that facilitates customer access to its services. The website and mobile app provide a user-friendly interface for customers to view their lab results and medical records, as well as manage their treatment plans. Additionally, the platform provides a comprehensive collection of resources and information on fertility. Another key component of Progyny's offering is its financing options. Fertility treatments can be expensive, and many insurance plans do not cover them. However, Progyny has developed its own financing tools to help customers bear the costs of treatment. The company offers flexible financing options, discounts for self-pay patients, and a special membership, among other options. Progyny aims to provide a comprehensive suite of services that meet the needs and desires of its customers. The company focuses on delivering cutting-edge technologies to improve the success rate of fertility treatments, as well as an unmatched customer experience. Progyny strives to be a reliable partner for its customers, supporting them at every step of their fertility journey.
The expected revenue of Progyny is 1.37 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Progyny is 110.87 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Progyny is currently 22.33. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Progyny stock.
The price-to-sales ratio (P/S) of Progyny is currently 1.80. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Progyny stock.
The Eulerpool Quality Score for Progyny is 5/10.
The ISIN of Progyny is US74340E1038. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Progyny is A2PT5Q. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Progyny is PGNY. The ticker symbol is used to trade Progyny shares on the stock exchange.
Progyny stock
Progyny Ticker
Progyny FIGI
All fundamentals and in-depth analysis of Progyny
Our stock analysis for Progyny stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Progyny. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.